The spread of novel betacoronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly escalated to a pandemic unseen for generations. With ramifications not before witnessed during peacetime, the medical community stands to face a very tough year.
Cancer patients represent a population at elevated risk for serious viral disease due to the immunosuppressive nature of both malignancy and anticancer treatments such as chemotherapy.1-3 Therefore, cancer patients may be at an increased risk of COVID-19 infection and henceforth face a poorer prognosis.
Reusser P. Management of viral infections in immunocompromised cancer patients. Swiss Medical Weekly. 2002;132:374–378.
Sica A, Massarotti M. Myeloid suppressor cells in cancer and autoimmunity. J Autoimmun. 2017 Dec;85:117–125.
Komada Y, Zhang SL, Zhou YW et al. Cellular immunosuppression in children with acute lymphoblastic leukemia: Effect of consolidation chemotherapy. Cancer Immunology. 1992;35:271–276.
VJOncology is intended for Healthcare Professionals only
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest hemonc news and updates